Navigation Links
Xytis Names Gordon H. Busenbark as Chief Financial Officer
Date:10/19/2007

IRVINE, Calif., Oct. 19 /PRNewswire/ -- Xytis Inc., a privately held biotechnology company focused on developing novel therapeutics to treat central nervous system (CNS) diseases, today announced that Gordon H. Busenbark has joined the company as Chief Financial Officer. Mr. Busenbark has more than 25 years of experience in the pharmaceutical, biotechnology and medical devices industries. During a 23 year career at Baxter Healthcare, Mr. Busenbark held a number of senior-level financial, operational and general management positions in both the U.S. and Europe. This included roles as Chief Financial Officer of Immuno AG when the company was acquired by Baxter, and President of Baxter's global Plasma Therapeutics business. Mr. Busenbark's most recent role was as Chief Financial Officer at Encysive Pharmaceuticals, where his accomplishments included raising more than $100 million in debt and equity financing.

"We are very pleased to have Gordon join Xytis," said Vincent F. Simmon, CEO and President. "He brings great financial and operational experience, both from a large pharmaceutical company perspective as well as from that of a smaller biotechnology company. Gordon joins us at an exciting time for Xytis. Our Phase 2 clinical trial in Traumatic Brain Injury (TBI) is approximately half way enrolled. Also, there is considerable partnering interest in two of our pre-clinical programs; positive allosteric modulators of GABA-A receptor and of alpha-7 nicotinic acetylcholine receptors. His experience and assistance in financing and marshalling these programs forward will be greatly welcomed."

Mr. Busenbark has both a B.S. in Accounting and an MBA from the University of Utah.

About Xytis

Xytis Inc. is a privately held discovery and development biopharmaceutical company, headquartered in Irvine, California, and having a clinical development group in Nyon, Switzerland, focused on innovative CNS drug candidates. The Company's investors include At
'/>"/>

SOURCE Xytis Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , RARITAN, N.J., Dec. 4 Depre...on Deficit Hyperactivity Disorder (ADHD), sleep di...ties reported to occur more often in people who sa...ose without an epilepsy diagnosis, according to a ...the U.S. ,, Findings from " CNS-Related Comorbi...
(Date:12/3/2009)... , SUNNYVALE, Calif., Dec. 3 /PRNewswire-Firs...biopharmaceutical company focused on developing an...for the treatment of immune mediated diseases and ...t and conference call on, Tuesday, December 8, 200...d 8:00am Pacific Time) to discuss clinical data re...
(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEG... - SPC3649 Successfully Inhibits miR-122, a micr...Thereby Significantly Reducing Hepatitis C,Virus i...ted With the,Hepatitis C Virus , - SPC364...Resistance and,No Serious Adverse Events in the Tr...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Twin Triumph Productions and 26apos 3BThe Power of Two 26apos 3B Go to Japan 57924 1Twin Triumph Productions and 26apos 3BThe Power of Two 26apos 3B Go to Japan 57924 2Twin Triumph Productions and 26apos 3BThe Power of Two 26apos 3B Go to Japan 57924 3Expert calls for new cancer research priorities 57920 1Expert calls for new cancer research priorities 57920 2Expert calls for new cancer research priorities 57920 3National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 1National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 2National Autism Center Releases Groundbreaking Report on Autism Treatments 57915 3
(Date:12/4/2009)...mmediately or 3 weeks later, study shows , ...surgical repair or reconstruction of multiple-liga... a new study has found. , Multiple-ligament kne... that can occur in high-impact car crashes or in c... to repair these injuries hasn,t been definitively...
(Date:12/4/2009)... Historic Effort but Points out Potential Risk if ...alth Care Reform ,, NEW YORK, Dec. 4 /PRNewsw...dicine today published a Perspective opinion pie...rwin Redlener, M.D., president, Children,s Health ...eparedness and Professor of Clinical Population &a...
(Date:12/4/2009)...okah, research shows , , FRIDAY, Dec. 4 ...cigarettes for smoking tobacco, researchers say. ,...o with a water pipe inhale carbon monoxide and nic...nd nicotine addiction. , The study included 31 ...g a water pipe and a single cigarette. After each ...
(Date:12/4/2009)...RNewswire-FirstCall/ -- When the spread of H1N1 fl...of Health Services needed to get more information ... Sonic Foundry, Inc. (Nasdaq: SOFO ), the recog...knowledge management, for a live webinar in which ... Services, will share how in-house webcasting reli...
(Date:12/4/2009)...c. 4 NeoGenomics, Inc.... Steven C. Jones has been appointed Executive Vice... joined the company as Chief Financial Officer. M...ternal financial affairs of the Company. In his n...gic initiatives on behalf of NeoGenomics as well a...
Breaking Medicine News(10 mins):Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3Health News:NeoGenomics Announces Executive Appointments 2
...zz' words today throughout the country are 'Dengu...sses, brought on by the bite of an infected Aedes ...s knolling in several Indian states. Dengue is the... to go out of hand unless a formidable solution ap...
... blood loss during surgery can mean all the differ...has been a nagging area for scientists//, who yet ...st bleeding in the operation room. Scientists in H...ry drastically. This is like a breath of fr...
... Surgical Vasectomy is in the midst of competition...endowed with the potential of giving the procedure...hers have devised a new ‘Intra Vas Device’ or IVD ...he sperms from traveling along each of the tubes, ...
...nment report released on Tuesday revealed that Bri...e data from the Organization// for Economic Co-Ope...alth Profile of England” report. According t...ny and Spain. The body mass index (BMI), height t...
...er Morris an authority in organ transplantation an... at Christian Medical College// and Hospital (CMCH...g he observed that need of the hour is to spread i...e doing so, the strength of celebrities, philanthr...
...h of October is observed as World Health Day globa...ober 10th 1992 as an annual activity of the World ...Secretary General Richard Hunter. Ever since then ... this year by the Federation focuses on " Building...
Other Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Crying Need for Awareness on Organ Donation in India: Sir Peter Morris 2Health News:Impact of Mental Illness on Suicide 2
Rheumatoid Factor (RF) Assay for Aeroset
Rheumatoid Factor II ELISA
...mpflug Analyzer is a high precision optical system...ysis of the anterior eye segment, based on a Revol... Disk. , GALILEI combines the advantages of t...curacy curvature data, while Scheimpflug imaging i...
...ility & capability together in this user-friendly,...ktop maginifcation., ,With its battery powered...cation device will meet any individual, education ...y it like a briefcase from room to room or across ...
Medicine Products: